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Abstract 
Background: To get a broader view of global ischemia-induced cerebral disorders at the metabolic level, a nuclear 
magnetic resonance-based metabolomic study was performed to evaluate the metabolic profile changes on regional 
brain tissues of female and male mice upon bilateral common carotid arteries occlusion (BCCAO) operation.
Results: Significant metabolic disorders were observed in both cerebral cortex and hippocampus tissues of the 
experimental mice upon global cerebral ischemic attack. Multiple amino acids were identified as the dominantly 
perturbed metabolites. It was also shown that although the metabolic profile change patterns in the brain tissues 
were quite similar in male and female BCCAO mice, metabolic disorders in the cortex tissues were more severe in the 
female mice than in the male mice.
Conclusions: In the present study, significant changes in amino acid metabolic pathways were confirmed in the 
early stage of global ischemia. Meanwhile, cerebral metabolic dysfunctions were more severe in the female BCCAO 
mice than in the male mice, suggesting that gender may play a role in different metabolic responses to the ischemic 
attack, which may provide an important hypothesis for a better understanding of the clinically observed gender-
dependent pathological outcome of cerebral ischemia.
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Background
Ischemic stroke, which is usually initiated by the acci-
dental occurrence of thrombosis, is one of the most 
common causes of death in the population over 65 years 
old. Endothelial dysfunction, neurovascular crosstalk 
perturbation, and blood brain barrier (BBB) disruption 
have been identified to be the risk factors for blood ves-
sel occlusion/ischemic stroke [1–3]. After the occurrence 
of cerebral thrombosis, focal brain ischemia develops 
in the brain tissues and then leads to a series of cellular 
disorders and metabolic disturbances including mito-
chondrial dysfunction [4], oxidative stress, NO deficit 
[5], inflammation [6], increased anaerobic glycolysis [7, 
8], aberrant turnover of protein synthesis [9], and dys-
function of glutamate-glutamine cycle [10] etc. All the 
above-mentioned cellular changes link to a final irrevers-
ible damage in the brain tissues. The underlying molecu-
lar mechanisms of ischemic stroke are quite complicated, 
and are not yet fully understood. Emerging systematic 
research approaches, such as genomics, proteomics, and 
metabolomics, provide new opportunities for getting a 
broader view of ischemia-induced cerebral disorders.
Genomic and proteomic studies can detect the changes 
that happened on gene and protein level, while metabo-
lomics can reveal whole metabolic profile changes of 
living systems in response to external stimuli such as dis-
ease-induced damage and drug treatments by monitoring 
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the endogenous low molecular weight metabolites [11–
15]. Metabolomics has proven to be valuable in the inves-
tigation of molecular mechanisms underlying various 
human diseases [16, 17]. In the present study, a nuclear 
magnetic resonance (NMR)-based metabolomic study, 
which has not ever been tried for the bilateral com-
mon carotid artery occlusion (BCCAO) ischemic mouse 
model, was performed to investigate the biochemical 
mechanisms of cerebral disorders happening in the early 
stage of global ischemic attack/stroke.
In Wang et  al.’s study, transient ischemia induced by 
BCCAO procedure has been demonstrated to cause 
cerebral functional changes (memory deficits) in experi-
mental mice. In the present study, the same BCCAO pro-
cedure was conducted in the experimental mice group 
to induce ischemic defects. Meanwhile, the sham mice 
group was subjected to the sham procedure by follow-
ing the same surgical procedure without artery occlu-
sion. The cortex and hippocampus tissues of BCCAO 
and sham-operation mice were obtained and subjected to 
NMR analysis 1 h after the surgery to evaluate the func-
tional state of regional brain tissues in the early stage of 
ischemic attack. Multivariate analysis of principal com-
ponent analysis (PCA), partial least squares discriminant 
analysis (PLS-DA), and orthogonal partial least squares 
discriminant analysis (OPLS-DA) were conducted to 
evaluate possible correlations between the metabolic 
profile changes and the variations in biological pathways 
in the BCCAO mice.
Results
1H NMR spectra of cerebral tissue samples
Representatives of two 1D 1H NMR spectra of the cortex 
tissue aqueous extracts obtained from the experimen-
tal and sham group mice were shown in Fig.  1, and 1D 
1H NMR spectra of hippocampus tissue samples were 
illustrated in Additional file  1: Figure S1. The assign-
ments (both chemical shift and multiplicity) of identi-
fied metabolites (Additional file 1: Table S1) were based 
on reported results [18, 19] and the Human Metabolome 
Database (HMDB). The NMR spectra of cortex tissue 
samples contained 26 assignable metabolites (Additional 
file 1: Tables S2, S3; Fig. 1), while the hippocampus tissue 
samples contained 25 assignable metabolites (Additional 
file 1: Tables S2, S3, Figure S1). The identified metabolites 
include amino acids (leucine, isoleucine, valine, alanine, 
lysine, glutamine, glutamate, aspartate, N-acetylaspar-
tate (NAA) and tyrosine, γ-aminobutryric acid (GABA), 
glycine), carboxylic acid (succinate, malate, lactate, 
isobutyrate, malonate, creatine), membrane component 
(choline, sn-glycero-3-phophocholine (GPC), o-phos-
phocholine), oxidative stress-related  metabolites (tau-
rine), and nitrogen-containing heterocyclic molecules 
(adenosine monophosphate (AMP), dimethylamine 
(DMA), carnitine and myo-inositol).
Metabolic disorders in cerebral cortex of BCCAO mice
The PCA (Additional file 1: Figure S2, Figure S3), PLS-
DA (Additional file  1: Figure S2, Figure S3) and OPLS-
DA (Figs.  2, 3) score plots revealed clear separations 
between the cortex samples from female/male experi-
mental group and the sham group. The permutation 
test data (Additional file  1: Figure S2, Figure S3), in 
which all of the permutated Q2 values to the left were 
lower than the original data point to the right, indi-
cating that the original PLS-DA and OPLS-DA mod-
els were valid. Based on the determined coefficient 
numbers of (|r|) and VIP from the back-transformed 
OPLS-DA coefficient plots and the p values from the 
student’s t tests, the major discriminative metabolites 
for each group were indentified in the pair-wised com-
parison (Figs. 2, 3, Additional file 1: Tables S2, S3). Upon 
BCCAO operation, increased levels of leucine, isoleu-
cine, valine, alanine, lysine, GABA, succinate, glutamine 
and tyrosine and decreased levels of glutamate, aspar-
tate, o-phosphocholine, taurine and NAA were observed 
in both the female and male cortex tissues. Additional 
metabolite perturbations including the up-regulations 
of isobutyrate, DMA, malonate, myo-inositol, and the 
down-regulation of AMP were detected in the female 
cortex samples, suggesting that more severe metabolic 
damage was induced by global cerebral ischemia/reper-
fusion in the female cortex region.
Metabolic disorders in hippocampus of BCCAO mice
Distinct separations between the hippocampus sam-
ples from the female/male experimental group and the 
sham group were revealed by PCA (Additional file  1: 
Figure S2, Figure S3), PLS-DA (Additional file  1: Fig-
ure S2, Figure S3) and OPLS-DA (Figs. 2, 3) score plots. 
The validation plots obtained by permutation tests 
with 350 permutated models from the first component 
(Additional file  1: Figure S2, Figure S3) indicated that 
the original PLS-DA and OPLS-DA models were valid. 
According to the determined coefficient values of VIP 
and |r| (Figs.  2, 3, Additional file  1: Tables S2, S3) and 
the p values, the major discriminative metabolites for 
the hippocampus groups were identified. Upon BCCAO 
procedure, the levels of isoleucine, valine, alanine, 
GABA, malonate and glycine were up regulated and the 
levels of glutamate and o-phosphocholine were down 
regulated in both the female and male hippocampus 
tissues. Meanwhile, the increased levels of leucine and 
tyrosine and the decreased levels of aspartate and AMP 
were observed in the female hippocampus samples only, 
and the increased level of glutamine and the decreased 
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level of GPC were only detected in the male hippocam-
pus tissues.
Ca2+‑induced brain mitochondrial swelling
Ca2+ exposure could induce significant swelling of the 
isolated mitochondria. The swelling level is estimated 
by changes in light scattering at 540 nm as monitored 
with a microplate reader. A decrease in absorbance 
indicates an increase in mitochondrial swelling, and a 
faster decrease in absorbance during experimental time 
scale is usually caused by mitochondria dysfunction. 
The decrease slope of the absorbance at 540  nm from 
cycle 1 to cycle 30 was calculated with linear regres-
sion to represent mitochondrial swelling degree. In our 
study, in comparison with the female/male sham group, 
the Ca2+-induced mitochondrial swelling in the cortex 
tissues of female/male BCCAO group mice exhibited a 
much more rapid decrease in swelling slope (Additional 
file 1: Figure S4A) and in absorbance during the 30-min 
experimental duration (Additional file  1: Figure S4B). 
Although the changes in mitochondrial swelling are 
statistically significant, the mild increase suggests that 
the BCCAO operation induced slight mitochondria 
dysfunction of the cortex tissues of experimental mice.
Discussion
To get a broader view of the biochemical mechanisms 
of ischemia-induced cerebral disorders, we performed 
a holistic evaluation of the metabolic profile perturba-
tions that occurred in regional mouse brain tissues upon 
BCCAO operation. The metabolomics data showed that 
global ischemia/reperfusion induced significant meta-
bolic disorders in the cerebral cortex and hippocampus 
tissues of the experimental mice. In the meantime, it also 
demonstrated that upon ischemia/reperfusion opera-
tion a dominant number of perturbed metabolites in 
the cerebral cortex and hippocampus of experimental 
mice were amino acids. These amino acids functioned 
as energy providing materials and/or functional compo-
nents in brain tissues (Additional file  1: Tables S2, S3). 
Besides, it is worth noting that the female BCCAO mice 
showed more severe metabolic disorders in their cortex 
tissues than the male mice (Additional file 1: Tables S2, 
S3).
Potential biochemical mechanisms related 
to ischemia‑induced cerebral disorders of female mice
As it has been mentioned above, significant metabolic 
disorders were observed in the cerebral cortex and 
Fig. 1 The 600-MHz 1H NMR NOESY spectra (δ 0.9–4.7, 5.3–9.4) of aqueous extracts from the cortex tissues of mice in female experimental group 
(a) and female sham group (b). The abbreviations of metabolites were shown in Additional file 1: Table S1
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hippocampus tissues of female BCCAO mice. Clear 
group clustering for the female experimental group and 
the female sham group were revealed by the OPLS-DA 
score plots (Fig. 2). Besides, it was clearly shown by the 
metabolomics analysis data that the induced metabolic 
dysfunctions in regional brain tissues of female mice 
focused on energy metabolism, amino acid metabolism, 
oxidative stress, and cell state-related pathway.
After the BCCAO procedure, the level of AMP dra-
matically decreased in the cortex and hippocampus tis-
sues of female mice (Fig. 4), indicating insufficient energy 
supply in these tissues. Consistent with this observation, 
the levels of some well-known energy-providing amino 
acids, including leucine, isoleucine, valine, tyrosine and 
lysine, increased significantly in brain tissues of female 
BCCAO mice, indicating that protein breaking-down 
was up-regulated (Fig.  4) [11, 20, 21]. Furthermore, 
down-regulations were observed for glutamate and 
aspartate upon ischemia/reperfusion damaging. Since 
glutamate and aspartate could be directly transformed to 
tricarboxylic acid cycle (TCA cycle) intermediate 2-oxo-
glutaramate and oxaloacetate, respectively, we believe 
that the acute depletions of these two amino acids in the 
cortex and hippocampus tissues of female mice might 
be due to their remediation and compensation in the 
energy-providing TCA cycle [22, 23]. This hypothesis is 
also supported by the results that mitochondria dysfunc-
tion in the cerebral cortex cells of female BCCAO mice 
was somehow more severe than that of the female mice 
from the sham group (Additional file  1: Figure S4). The 
changes of above-mentioned energy-related metabolites 
and the mitochondria state under ischemia suggest an 
Fig. 2 The OPLS-DA score plots and loading plots derived from the 600 MHz 1H NMR spectra of cortex samples (a, a′) and hippocampus samples 
(b, b′) extracted from the mice in female sham group (filled square) and female experimental group (triangle). Each group contains six samples 
(n = 6). The values of Q2 parameter, which were > 0.4, indicated that the established OPLS-DA models were valid. Those metabolites with the value 
of variable importance in the projection (VIP) bigger than 1 and the absolute value of correlation coefficient |r| greater than the cutoff value of 0.576 
were defined to be the discriminative metabolites for group clustering. The discriminative metabolites with the value of correlation coefficient 
r > 0.576 indicated that their levels increased upon the global ischemic attack. And those discriminative metabolites with the value of correlation 
coefficient r < −0.576 indicated that their levels decreased upon the global ischemic attack
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insufficient energy supply in the cortex cells. Since the 
brain consists of different cell types e.g. neurons and glial 
cells, it will be interesting to evaluate which type of brain 
cell mainly contributes to mitochondrial dysfunction fol-
lowing ischemic insult. However, with the lack of efficient 
methods to separate neuronal and glial cells from the 
tissue homogenates, new techniques will be needed for 
achieving this goal.
In brain tissues, amino acids not only work as energy-
providing materials, many, including GABA, glycine, etc., 
also serve as functional neurotransmitters. In our study, 
upon ischemia/reperfusion, GABA and glycine were up 
regulated in the hippocampus and/or cortex tissues of 
female mice, and these observations are consistent with 
the previously published data by Andine et  al. [24] and 
Melani et  al. [25]. Both the releasing of GABA and the 
up-regulation of glycine represent the self-protective 
efforts of brain tissues against BCCAO-induced dysfunc-
tions [26–28].
Other than the disturbed energy metabolism and amino 
acid metabolism, oxidative stress was also observed in 
the regional brain tissues of female BCCAO mice. Upon 
ischemia/reperfusion operation, the levels of three oxi-
dative stress-related metabolites including taurine, suc-
cinate, and malonate were significantly disturbed in the 
cortex tissues of BCCAO female mice, while the increased 
level of malonate was observed in the hippocampus sam-
ples from the female experimental group (Fig.  4). Banks 
et al. [29] found that pretreatment of the cells with taurine 
could reduce oxidative stress. In the work reported by Bal-
kan et al. [30], taurine administration could protect rats’ 
liver from thioacetamide-induced cirrhosis by decreasing 
Fig. 3 The OPLS-DA score plots and loading plots derived from the 600 MHz 1H NMR spectra of cortex samples (a, a′) and hippocampus samples 
(b, b′) extracted from the mice in male sham group (filled square) and male experimental group (triangle). The male hippocampus sham group con-
tains five samples (n = 5), and the other three groups contain six samples (n = 6) in each. The values of Q2 parameter, which were >0.4, indicated 
that the established OPLS-DA models were valid. Those metabolites with the value of variable importance in the projection (VIP) bigger than 1 and 
the absolute value of correlation coefficient |r| greater than the cutoff value 0.576 (the sum of two group samples equals to 12, n = 12) or 0.602 (the 
sum of two group samples equals to 11, n = 11) were defined to be the discriminative metabolites for group clustering. The discriminative metabo-
lites with the value of correlation coefficient r > 0.576 (n = 12) or r > 0.602 (n = 11) indicated that their levels increased upon the global ischemic 
attack. And those discriminative metabolites with the value of correlation coefficient r < −0.576 (n = 12) or r < −0.602 (n = 11) indicated that their 
levels decreased upon the global ischemic attack
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oxidative stress. Therefore, the observed down-regulation 
of taurine in the cortex of female BCCAO mice suggested 
that oxidative stress may be induced by ischemia/reper-
fusion. Meanwhile, up-regulations of malonate and suc-
cinate further supported this hypothesis. Malonate has 
been found to be a reversible succinate dehydrogenase 
(SDH) inhibitor. SDH inhibition was reported to serve as 
a reactive oxygen species (ROS) sensor for ROS/oxidative 
stress [31, 32]. Therefore, inhibition of the activity of SDH 
by malonate may lead to accumulation of succinate in the 
cortex of female BCCAO mice.
Finally, although multiple protecting mechanisms, 
including up-regulation of protein break-down and inhib-
itory neurotransmitter emission, were initiated, neu-
ronal dysfunction of female BCCAO mice still occurred. 
The levels of cell-state indicators, including NAA, myo-
inositol, and o-phosphocholine, in the cortex tissues of 
female BCCAO mice were significantly perturbed, and 
in the hippocampus tissues of female BCCAO mice, the 
level of o-phosphocholine was significantly down regu-
lated (Fig.  4). NAA, which predominantly presents in 
neuronal cells and acts as a neuronal marker [33, 34], was 
Fig. 4 The potential metabolic pathways disturbed by ischemia in the regional brain tissues of female and male experimental group mice
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down regulated in the cortex of female BCCAO mice in 
the present study. This observation indicated that signifi-
cant neuronal dysfunction happened in the cortex region. 
Another cell-state indicator, o-phosphocholine, was also 
found to be down regulated in the cortex and hippocam-
pus tissues of female BCCAO mice. Since o-phospho-
choline is an important component of cell membrane 
phospholipids, its decreased level suggested that cell 
membrane dysfunction was induced by ischemia/rep-
erfusion in these two brain regions. Myo-inositol is one 
of the important cellular osmolytes. The increased level 
of myo-inositol in the cortex tissues of female BCCAO 
mice indicated local osmolality disorders [35], which inti-
mately related to the decrease of the neuronal cell vitality.
Potential biochemical mechanisms related 
to ischemia‑induced cerebral disorders of male mice
Compared with the female experimental mice, after 
ischemia/reperfusion operation, similar metabolic pro-
file change patterns were observed in the regional brain 
tissues of the BCCAO male mice (Fig.  4). The up-regu-
lations of tyrosine, leucine, lysine, valine, isoleucine, 
glutamine and the down-regulations of glutamate and 
aspartate in the cortex and/or hippocampus of male 
BCCAO mice were detected. These results indicated that 
the energy metabolism disorders occurred upon global 
ischemia. However, no significant change was detected 
in AMP, which indicated that the total energy supply in 
regional brain tissues of male mice have not been signifi-
cantly affected by BCCAO procedure. For the functional 
amino acids including GABA and glycine, their levels 
increased in the cortex of male BCCAO mice, indicating 
that ischemia/reperfusion also triggered similar inhibi-
tory neurotransmitter activation to which occurred in 
the cortex of female BCCAO mice (Fig.  4). Compared 
with the female BCCAO mice, a similar oxidative stress 
was also detected in the cortex and hippocampus tissues 
of male BCCAO mice. However, it is worth noting that, 
although sharing a similar metabolic profile change pat-
tern with the BCCAO female mice, the cortex region of 
male BCCAO mice had fewer metabolites (AMP, isobu-
tyrate, DMA, malonate, and myo-inositol) perturbed 
by the cerebral ischemia/reperfusion (Additional file  1: 
Tables S2, S3; Fig.  4). And these data suggest that the 
ischemia-induced metabolic dysfunctions in the cortex of 
female BCCAO mice were more severe than in the male 
ones.
Conclusions
In conclusion, during the early stages of global cerebral 
ischemia, multiple amino acids were the dominantly 
affected metabolites in brain tissues of the experimental 
mice, suggesting that the changes of amino acid metabolic 
pathways play key roles in the early stage of cerebral 
ischemia-related diseases. In addition, the change pat-
terns of the cerebral metabolic profile induced by the 
global ischemia were almost the same in the female as in 
the male mice, as reflected by the well-matched identi-
fied perturbed metabolites in these two gender groups. 
However, the extent of dysfunctions that occurred in the 
cortex tissues of female ischemic mice were more severe 
than that which occurred in the cortex tissues of male 
ischemic mice. Fewer metabolites were disturbed by the 
BCCAO operation in the cortex of male mice, with AMP 
level only significantly affected in regional brain tissues of 
female BCCAO mice, but not in the male ones. Overall, 
for the first time, our study verified the different impact 
of early stage global ischemia on cerebral metabolites in 
male and female mice, which may shed some light on the 
progression of global ischemia-associated diseases and 
provide an important hypothesis for a better understand-
ing of the clinically observed gender-dependent patho-
logical outcomes in cerebral ischemia.
Methods
Reagents and materials
NaH2PO4∙2H2O and Na2HPO4∙12H2O (all in analyti-
cal grade) were provided by Sinopharm Chemical Rea-
gent Co. Ltd. (Shanghai, China). D2O (99.9 % in D) was 
obtained from Sigma Chemical Corp. (St. Louis, MO, 
USA).
Animal cerebral ischemia/reperfusion injury induced 
by BCCAO operation
ICR strain mice (8–10  weeks, SPF degree, 22–25  g in 
weight), were supplied by the Shanghai Experimental 
Animal Center, Chinese Academy of Sciences (Shang-
hai, China). All animals were housed in colony cages on 
a 12/12-h light/dark cycle at an ambient temperature of 
22–25 °C and 50–60 % relative humidity. They were pro-
vided with a certified standard diet and tap water ad libi-
tum during the experiments.
A total number of 24 mice prepared for NMR study 
were randomly divided into four groups with six mice 
in each group: the female sham group, the female 
experimental group, the male sham group and the male 
experimental group. Additional mice were randomly 
divided into four groups with 6–8 mice in each group 
for measurement of brain mitochondria swelling: the 
female sham group, the female experimental group, the 
male sham group, and the male experimental group. 
All the mice in experimental groups were then sub-
jected to the surgical procedure of bilateral common 
carotid artery occlusion and reperfusion by following 
the protocol reported previously [36–38]. Briefly, at the 
beginning of the procedure, the mice were anesthetized 
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with 10  % chloral hydrate by intraperitoneal injection 
(3.5  ml/kg). Then, an incision was made in the mid-
dle of mouse neck, and the bilateral common carotid 
arteries were isolated. Both arteries were then occluded 
twice with microvascular clips for 10  min each time. 
Right after the first occlusion procedure, a 15-min rep-
erfusion was applied (ischemia for 10  min—reperfu-
sion for 15 min—ischemia for 10 min). The mice were 
kept warm (body temperature of 35  °C) during the 
whole surgical procedure. After the procedure, each 
mouse was further supplemented with 1  mL normal 
saline (NS) by intraperitoneal injection. For those mice 
in the sham groups, a sham procedure was performed 
following the same surgical procedure described above 
but without artery occlusion and normal saline sup-
plementation. Of note, due to the poor scan quality of 
original NMR spectra caused by limited quantities of 
mouse hippocampus tissues obtained, one hippocam-
pus sample in the sham male group was excluded from 
the analysis.
Preparation of brain mitochondria
Brain mitochondria were isolated from male and female 
ICR mice in experimental and sham groups according to 
previously reported methods [39, 40] with brief modifica-
tion. Each mouse was decapitated and the whole cortex 
from both hemispheres was rapidly removed, washed, 
minced, and homogenized in ice-cold isolation buffer 
(320 mM sucrose, 10 mM Tris–HCl, 1 mM EDTA, 0.1 % 
BSA, pH 7.4) with Dounce homogenizer. The homogen-
ate was centrifuged at 1000  rpm for 5  min at 4  °C. The 
supernatant was collected and subjected to another cen-
trifugation at 1000  rpm for 5 min at 4  °C, and then the 
supernatant was centrifuged at 10,000 rpm for 10 min at 
4  °C. The final mitochondrial pellet was resuspended in 
an ice-cold resuspension buffer and protein concentra-
tions were adjusted to 0.6  mg/mL. The mitochondrial 
samples were then ready for measurement of mitochon-
drial swelling.
Analysis of mitochondrial swelling
Mitochondrial swelling was measured by following a 
previously described protocol [41]. Briefly, after being 
initiated by 250 mM calcium chloride and 5 mM sodium 
succinate, the osmotic volume changes of mitochon-
dria were estimated by changes in light scattering at 
540 nm (30 °C) as monitored continuously for 30 cycles 
(the interval between trials was 30  s) with a microplate 
reader (Envision, Perkin Elmer). A decrease in absorb-
ance indicates an increase in mitochondrial swelling. The 
decreased slope of the absorbance at 540 nm from cycle 1 
to cycle 30 was calculated with linear regression to repre-
sent mitochondrial swelling degree.
NMR sample preparation
One hour after the surgery, all of the experimental mice 
were sacrificed by decapitation. The brain tissue samples 
from the left hemisphere of the cortex and hippocampus 
were then quickly removed from each mouse, placed in 
the hard tissue-homogenizing tube, snap-frozen in liquid 
nitrogen and subsequently stored at −80 °C before NMR 
analysis.
Lyophilized aqueous brain extracts were prepared 
using the methanol/chloroform/water system as previ-
ously reported [12, 42]. The mixtures were allowed to 
thaw for 3 min, and then followed by 2 × 20 s beating of 
5000  rpm with a 20  s pause between the bead beatings 
using a tissue homogenizer (precellys 24, Bertin tech-
nologies, Villeurbanne, France). After a 5-min incuba-
tion at 4  °C, the extracted samples were centrifuged at 
12,000 rpm for 10 min at 4 °C. The upper aqueous phase 
was transferred into a marked 15 mL centrifugation tube 
and lyophilized. The powder of the extract was dissolved 
in 550  μL of phosphate buffer (Na2HPO4/NaH2PO4, 
0.2  M, pH 7.4) and vortexed. After a centrifugation 
(11,000 rpm) at 4 °C for 10 min had been done, aliquots 
of the supernatants (500 μL) were transferred into 5-mm 
NMR tubes for NMR data acquisition.
1H NMR data acquisition
All NMR spectra were recorded at 298  K on a Bruker 
Avance III 600 NMR spectrometer (Bruker Biospin, 
Germany) equipped with a cryogenic probe operat-
ing at 600  MHz for 1H resonance. NMR data for each 
sample was recorded using a solvent-suppressed 1D 1H 
NOESY (NoesyPr1d) pulse sequence (RD-90°-t1-90°-
tm-90°-ACQ). For the spectra of cortex samples, four 
dummy scans and 256 free induction decays (FIDs) were 
collected into 64 K data points, with a spectral width of 
9578.54  Hz. For the spectra of hippocampus samples, 
four dummy scans and 336 FIDs were collected into 64 K 
data points, with a spectral width of 9578.54 Hz.
Multivariate statistical analysis
Processed 1H NMR spectra were referenced to the methyl 
group of creatine at δ 3.043 and manually aligned using 
the software of MestReNova (Version 8.0, Mestrelab 
Research SL). For the spectra of cortex samples, the spec-
tral region ranging from δ 0.712 to δ 9.367 was divided 
into 2886 integral bins with a bin width of 0.003  ppm. 
Moreover, the spectral regions ranging from δ 3.319 to δ 
3.392 and from δ 4.678 to δ 5.230 were removed from the 
analysis to eliminate the effects of signals from residual 
methanol and imperfect water suppression. For the spec-
tra of hippocampus samples, the spectral region ranging 
from δ 0.721 to δ 9.381 was bucketed into 2888 integral 
bins with a bin width of 0.003 ppm. The spectral regions 
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ranging from δ 3.321 to δ 3.391 and from δ 4.540 to δ 
5.230 were eliminated from the analysis due to the same 
reasons as those mentioned above.
The integrals of resulting metabolites were normalized 
to the sum of spectral intensities of all identified metabo-
lites to compensate for the differences in the concentra-
tions of samples. Subsequently, the integral values were 
imported to SIMCA-P +  12.0 software package (Umet-
rics, Umeå, Sweden) for PCA, PLS-DA and OPLS-DA 
analysis with unit variance (UV) scaling. The PCA and 
PLS-DA score plots were visualized with the first prin-
cipal component (t[1]) and the second principal compo-
nent (t[2]), while OPLS-DA plots were calculated with 
the first principal component (t[1]) and the orthogonal 
component (to[1]). The parameters Q2 (cum) and R2X 
(cum) were calculated to test the validity of the model 
against overfitting. The six-fold cross-validation method 
and permutation test for 350 times with the first com-
ponent were carried out to measure the robustness of 
the PLS-DA model. The correlation coefficients of the 
variables relative to the first predictive component in the 
OPLS-DA model were extracted from S-plot. Cutoff val-
ues with significant level of 0.05 were applied to identify 
variables that were responsible for the discriminations of 
the groups [43]. The values of variable importance in the 
projection (VIP) were also used to evaluate the differen-
tiating metabolites with the VIP value >1, which contrib-
uted significantly to the group clustering. The OPLS-DA 
loading plots, in which the VIP and r values of metabo-
lites are displayed, were used to illustrate the relative 
metabolite changes induced by ischemia.
Group means of metabolites’ integrals were expressed 
as the mean ±  std (standard deviation) and the average 
changes of metabolites between the experimental group 
and sham group were calculated (Additional file 1: Tables 
S2, S3) [44]. Significant differences in the mean values 
were evaluated by Student’s t test and multivariate sta-
tistical analysis. Statistical significance was considered at 
two or more requirements among “VIP > 1, |r| > the cut-
off value and p < 0.05” obeying the boundary conditions.
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0.9-4.7, 5.3-9.4) of aqueous extracts from the hippocampus tissues of mice 
in female model group (A) and female sham group (B). The abbreviations 
of metabolites were denoted in Table S1. Figure S2. The PCA score plots, 
PLS-DA score plots and their corresponding validation plots derived from 
the 600 MHz 1H NMR spectra of cortex samples (A, A’, A’’) and hippocam-
pus samples (B, B’, B’’) extracted from the mice in female sham group (■) 
and female model group (▲). The validation plots were obtained by 
using a permutation test that was randomly permuted for 350 times with 
the first component extracts. ▲ is for R2Y (cum), and ■ is for Q2 (cum). 
The vertical axis of validation plot represents the R2 and Q2 values, and 
the horizontal axis (A’’, B’’) represents the correlation coefficients. Figure 
S3. The PCA score plots, PLS-DA score plots and their corresponding vali-
dation plots derived from the 600 MHz 1H NMR spectra of cortex samples 
(A, A’, A’’) and hippocampus samples (B, B’, B’’) extracted from the mice in 
male sham group (■) and male model group (▲). The validation plots 
were obtained by using a permutation test that was randomly permuted 
for 350 times with the first component extracts. ▲ is for R2Y (cum), and ■ is for Q2 (cum). The vertical axis of validation plot represents the R2 
and Q2 values, and the horizontal axis (A’’, B’’) represents the correla-
tion coefficients. Of note, due to the poor scan qualities of original NMR 
spectra caused by the limited quantities of mouse hippocampus tissues, 
one hippocampus sample in the sham male group was excluded from 
the analysis. Figure S4. Influence of BCCAO on mitochondrial swelling. 
(A). The Ca2+ induced mitochondria swelling in the cerebral cortex tissues 
of mice in female/male model versus sham group. *P < 0.05, ***P < 0.005 
versus sham group. (B). Representative swelling curves of mitochondria 
isolated from sham or BCCAO groups (Data are expressed as mean value 
of each group). Figure S5. The 600-MHz 1H NMR NOESY spectra of aque-
ous extracts with a total number of 11 samples from the hippocampus 
tissues of mice in sham groups. Figure S6. The 600-MHz 1H NMR NOESY 
spectra of aqueous extracts with a total number of 12 samples from the 
hippocampus tissues of mice in model groups. Table S1. NMR Resonance 
assignments of 26 aqueous metabolites extracted from regional brain 
tissues of experimental mice. Table S2. Quantitative comparisons of 
aqueous metabolites extracted from cerebral cortex and hippocampus 
tissues of female mice. Table S3. Quantitative comparisons of aqueous 
metabolites extracted from cerebral cortex and hippocampus tissues of 
male mice
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